Alere Inc (ALR)

42.79
0.41 0.95
NYSE : Health Care
Prev Close 43.20
Open 43.04
Day Low/High 42.61 / 43.97
52 Wk Low/High 31.47 / 54.13
Volume 507.21K
Avg Volume 1.15M
Exchange NYSE
Shares Outstanding 86.74M
Market Cap 3.78B
EPS 2.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Johnson & Johnson Sees Growth in Ophthalmology, Acquires Abbott Medical Optics

Johnson & Johnson Sees Growth in Ophthalmology, Acquires Abbott Medical Optics

The deal comes as Abbott works to complete two pending transactions worth nearly $40 billion combined and is the latest in the slew of ophthalmology deals.

Can Abbott Labs Find a Cure for Its Ailing Shares?

Can Abbott Labs Find a Cure for Its Ailing Shares?

Abbott Labs shares have been all over the place in the last year as the company makes deals. Investors are wondering if they should hold on.

Reaction to St. Jude Cybersecurity Threat May Be Overdone

Reaction to St. Jude Cybersecurity Threat May Be Overdone

The cardiac device maker has filed a lawsuit against the Muddy Waters, claiming the short-seller intentionally disseminated false and misleading information.

Abbott's Alere Pushback Could Color Future Dealmaking Efforts

Abbott's Alere Pushback Could Color Future Dealmaking Efforts

Potential targets of the medical device and diagnostics giant might request stricter parameters when structuring a deal, company followers say.

Alere Asks for September Trial in Case Against Abbott

Alere Asks for September Trial in Case Against Abbott

Alere claims that Abbott is slow-rolling the antitrust process on the companies' merger in an effort to kill the deal.

Alere (ALR) Stock Lower, Says Abbott Has 'Buyer's Remorse' Over Deal

Alere (ALR) Stock Lower, Says Abbott Has 'Buyer's Remorse' Over Deal

In a newly unsealed lawsuit, Alere (ALR) claims that Abbott (ABT) blocked the companies' $7.9 billion merger once it experienced 'buyer's remorse.'

Abbott's Acquisitions in Question as Issues Arise About Alere, St. Jude

Abbott's Acquisitions in Question as Issues Arise About Alere, St. Jude

The provider of point-of-care testing has filed a suit in Delaware Chancery Court against Abbott in an effort to complete their pending deal. Meanwhile, St. Jude, gets a griping short-seller.

Alere Issues Statement

Alere Issues Statement

Alere Receives FDA Clearance For Alere™ I RSV Rapid Molecular Test

Alere Receives FDA Clearance For Alere™ I RSV Rapid Molecular Test

Latest testing application on innovative Alere i molecular diagnostic platform detects RSV infections in 13 minutes or less

Alere Achieves IVD CE Mark For Its Alere™ Reader Lateral Flow Assay Analyzer

Alere Achieves IVD CE Mark For Its Alere™ Reader Lateral Flow Assay Analyzer

New Alere Reader Provides Consistency and Connectivity of Alere BinaxNOW® Legionella and S. pneumoniae Tests

Alere Opens New Diagnostics Manufacturing Facility In India

Alere Opens New Diagnostics Manufacturing Facility In India

New Manesar factory to produce critical diagnostics for detection of Malaria, Dengue, HIV and other infectious diseases

Here's a Reason Why Alere (ALR) Stock Is Soaring Today

Here's a Reason Why Alere (ALR) Stock Is Soaring Today

Alere (ALR) stock is rebounding today as concerns surrounding the Wall Street Journal's report fade of a subpoena from the Justice Department.

3 Health Care Stocks Pushing The Sector Higher

3 Health Care Stocks Pushing The Sector Higher

TheStreet highlights 3 stocks pushing the health care sector higher today.

Alere (ALR) Marked As A Dead Cat Bounce Stock

Alere (ALR) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Alere (ALR) as a "dead cat bounce" (down big yesterday but up big today) candidate

Alere (ALR) Stock Plunged on Criminal Probe, CNBC's DeAngelis Says

Alere (ALR) Stock Plunged on Criminal Probe, CNBC's DeAngelis Says

Shares of Alere (ALR) closed lower today after it was revealed that the Justice Department is seeking a criminal probe into the company's billing practices, CNBC's DeAngelis said.

Barbarian At The Gate: Alere (ALR)

Barbarian At The Gate: Alere (ALR)

Trade-Ideas LLC identified Alere (ALR) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Abbott's Alere Deal Continues To Face Uncertainty

Abbott's Alere Deal Continues To Face Uncertainty

The medical device company has two pending acquisitions worth just under $40 billion combined.

3 Stocks Pushing The Health Services Industry Higher

3 Stocks Pushing The Health Services Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Why Alere (ALR) Stock Is Jumping Today

Why Alere (ALR) Stock Is Jumping Today

Alere (ALR) stock is rising on Friday morning after the company said it expects to restate financial results and was upgraded to ‘buy’ at Canaccord Genuity.

Alere (ALR): Heavy Pre-Market Activity

Alere (ALR): Heavy Pre-Market Activity

Trade-Ideas LLC identified Alere (ALR) as a pre-market mover with heavy volume candidate

Alere™ HIV Combo Test Receives WHO Prequalification

Alere™ HIV Combo Test Receives WHO Prequalification

Broadened Access to a New 4th-generation Test in Resource-limited Countries Increases Opportunities to Meet Ambitious New Goals for Screening and Linkage to Care

Alere Q HIV-1/2 Detect Point-of-Care Molecular HIV Assay Receives WHO Prequalification

Alere Q HIV-1/2 Detect Point-of-Care Molecular HIV Assay Receives WHO Prequalification

Developing countries can now add point-of-care molecular Early Infant Diagnosis to national health algorithms, facilitating immediate linkage to care for HIV-positive newborns

SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Alere Inc. And Advises Investors With Losses To Contact The Firm

SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Alere Inc. And Advises Investors With Losses To Contact The Firm

Lundin Law PC announces a class action lawsuit has been filed against Alere Inc.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Alere Inc. Of Commencement Of Class Action Lawsuit And A Lead Plaintiff Deadline Of June 20, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Alere Inc. Of Commencement Of Class Action Lawsuit And A Lead Plaintiff Deadline Of June 20, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Alere Inc.